APO Research
Talk to an analyst

APO RESEARCH · REPORT

Foot and Mouth Disease (FMD) Vaccines

Foot and Mouth Disease (FMD) vaccines are vaccines that provide active acquired immunity to Foot and Mouth Disease (FMD). Foot and Mouth Disease (FMD) is a highly contagious viral disease that primarily affects cloven-hooved livestock and wildlife like cattle, pigs, sheep and goats.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Foot and Mouth Disease (FMD) vaccines are vaccines that provide active acquired immunity to Foot and Mouth Disease (FMD). Foot and Mouth Disease (FMD) is a highly contagious viral disease that primarily affects cloven-hooved livestock and wildlife like cattle, pigs, sheep and goats.

Selected research

Industry Growth & Trends

Global Foot and Mouth Disease (FMD) Vaccines Industry Growth and Trends Forecast to 2032

21 December 2025127 pages

Choose your research edition.

Industry ResearchFoot and Mouth Disease (FMD) Vaccines Industry Research Report 2026145 pages · $2,950 USDIndustry Growth & TrendsGlobal Foot and Mouth Disease (FMD) Vaccines Industry Growth and Trends Forecast to 2032127 pages · $3,450 USDMarket StructureGlobal Foot and Mouth Disease (FMD) Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Foot and Mouth Disease (FMD) Vaccines Market Outlook and Growth Opportunities 2026213 pages · $4,250 USDMarket Analysis & ForecastGlobal Foot and Mouth Disease (FMD) Vaccines Market Analysis and Forecast 2026-2032212 pages · $4,950 USD

Market perspective

Foot and Mouth Disease (FMD) vaccines are vaccines that provide active acquired immunity to Foot and Mouth Disease (FMD). Foot and Mouth Disease (FMD) is a highly contagious viral disease that primarily affects cloven-hooved livestock and wildlife like cattle, pigs, sheep and goats.

Global Foot and Mouth Disease (FMD) Vaccines key players include Jinyu Group, Indian Immunologicals, Tecon Group, CAHIC, etc. Global top four manufacturers hold a share nearly 60%.

Asia-Pacific is the largest market, with a share about 80%, followed by Central & South America, and Europe, both have a share over 15 percent.

Read the full market overview

In terms of product, Conventional Vaccines is the largest segment, with a share about 70%. And in terms of application, the largest application is Cattle, followed by Pig, Sheep and Goat , etc.

Report Scope

This report provides a structured, data-driven view of the global Foot and Mouth Disease (FMD) Vaccines market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Foot and Mouth Disease (FMD) Vaccines market size, estimates, and forecasts are presented in terms of sales volume (M Doses) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Foot and Mouth Disease (FMD) Vaccines market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Foot and Mouth Disease (FMD) Vaccines.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Foot and Mouth Disease (FMD) Vaccines market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Foot and Mouth Disease (FMD) Vaccines Market by Company

Jinyu Group

Cavet Bio

Indian Immunologicals

Tecon Group

CAHIC

Shen Lian

Biogenesis Bagó

BIGVET Biotech

Boehringer Ingelheim

MSD Animal Health

CEVA

FGBI

Bayer HealthCare

Brilliant Bio Pharma

VECOL

Sanofi (Merial)

VETAL

BVI

LIMOR

ME VAC

Agrovet

Foot and Mouth Disease (FMD) Vaccines Segment by Type

Emergency Vaccines

Conventional Vaccines

Foot and Mouth Disease (FMD) Vaccines Segment by Application

Cattle

Pig

Sheep and Goat

Others

Foot and Mouth Disease (FMD) Vaccines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Foot and Mouth Disease (FMD) Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Foot and Mouth Disease (FMD) Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Foot and Mouth Disease (FMD) Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Foot and Mouth Disease (FMD) Vaccines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Foot and Mouth Disease (FMD) Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Emergency Vaccines Table 2. Major Company of Conventional Vaccines Table 3. Global Foot and Mouth Disease (FMD) Vaccines Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Foot and Mouth Disease (FMD) Vaccines Sales by Type (2021-2026) & (M Doses) Table 5. Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share in Volume by Type (2021-2026) Table 6. Global Foot and Mouth Disease (FMD) Vaccines Sales by Type (2021-2026) & (US$ Million) Table 7. Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share in Value by Type (2021-2026) Table 8. Global Foot and Mouth Disease (FMD) Vaccines Price by Type (2021-2026) & (USD/K Doses) Table 9. Global Foot and Mouth Disease (FMD) Vaccines Sales by Type (2027-2032) & (M Doses) Table 10. Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share in Volume by Type (2027-2032) Table 11. Global Foot and Mouth Disease (FMD) Vaccines Sales by Type (2027-2032) & (US$ Million) Table 12. Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share in Value by Type (2027-2032) Table 13. Global Foot and Mouth Disease (FMD) Vaccines Price by Type (2027-2032) & (USD/K Doses) Table 14. North America Foot and Mouth Disease (FMD) Vaccines Sales by Type (2021-2026) & (M Doses) Table 15. North America Foot and Mouth Disease (FMD) Vaccines Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Foot and Mouth Disease (FMD) Vaccines Sales by Type (2021-2026) & (M Doses) Table 17. Europe Foot and Mouth Disease (FMD) Vaccines Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Foot and Mouth Disease (FMD) Vaccines Sales by Type (2021-2026) & (M Doses) Table 19. Asia-Pacific Foot and Mouth Disease (FMD) Vaccines Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Foot and Mouth Disease (FMD) Vaccines Sales by Type (2021-2026) & (M Doses) Table 21. Latin America Foot and Mouth Disease (FMD) Vaccines Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Sales by Type (2021-2026) & (M Doses) Table 23. Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Sales by Type (2021-2026) & (US$ Million) Table 24. Foot and Mouth Disease (FMD) Vaccines Industry Trends Table 25. Foot and Mouth Disease (FMD) Vaccines Industry Drivers Table 26. Foot and Mouth Disease (FMD) Vaccines Industry Opportunities and Challenges Table 27. Foot and Mouth Disease (FMD) Vaccines Industry Restraints Table 28. Global Foot and Mouth Disease (FMD) Vaccines Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Company (2021-2026) Table 30. Global Foot and Mouth Disease (FMD) Vaccines Sales by Company (2021-2026) & (M Doses) Table 31. Global Foot and Mouth Disease (FMD) Vaccines Sales Share by Company (2021-2026) Table 32. Global Foot and Mouth Disease (FMD) Vaccines Market Price by Company (2021-2026) & (USD/K Doses) Table 33. Global Foot and Mouth Disease (FMD) Vaccines Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Foot and Mouth Disease (FMD) Vaccines Major Company Production Sites and Headquarters Table 35. Global Foot and Mouth Disease (FMD) Vaccines Company, Product Type & Application Table 36. Global Foot and Mouth Disease (FMD) Vaccines Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Foot and Mouth Disease (FMD) Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Foot and Mouth Disease (FMD) Vaccines Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Foot and Mouth Disease (FMD) Vaccines Sales by Region (2021-2026) & (M Doses) Table 41. Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share in Volume by Region (2021-2026) Table 42. Global Foot and Mouth Disease (FMD) Vaccines Sales by Region (2021-2026) & (US$ Million) Table 43. Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share in Value by Region (2021-2026) Table 44. Global Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 45. Global Foot and Mouth Disease (FMD) Vaccines Sales by Region (2027-2032) & (M Doses) Table 46. Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share in Volume by Region (2027-2032) Table 47. Global Foot and Mouth Disease (FMD) Vaccines Sales by Region (2027-2032) & (US$ Million) Table 48. Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share in Value by Region (2027-2032) Table 49. Global Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2027-2032) Table 50. Global Foot and Mouth Disease (FMD) Vaccines Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Foot and Mouth Disease (FMD) Vaccines Sales by Application (2021-2026) & (M Doses) Table 52. Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share in Volume by Application (2021-2026) Table 53. Global Foot and Mouth Disease (FMD) Vaccines Sales by Application (2021-2026) & (US$ Million) Table 54. Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share in Value by Application (2021-2026) Table 55. Global Foot and Mouth Disease (FMD) Vaccines Price by Application (2021-2026) & (USD/K Doses) Table 56. Global Foot and Mouth Disease (FMD) Vaccines Sales by Application (2027-2032) & (M Doses) Table 57. Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share in Volume by Application (2027-2032) Table 58. Global Foot and Mouth Disease (FMD) Vaccines Sales by Application (2027-2032) & (US$ Million) Table 59. Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share in Value by Application (2027-2032) Table 60. Global Foot and Mouth Disease (FMD) Vaccines Price by Application (2027-2032) & (USD/K Doses) Table 61. North America Foot and Mouth Disease (FMD) Vaccines Sales by Application (2021-2026) & (M Doses) Table 62. North America Foot and Mouth Disease (FMD) Vaccines Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Foot and Mouth Disease (FMD) Vaccines Sales by Application (2021-2026) & (M Doses) Table 64. Europe Foot and Mouth Disease (FMD) Vaccines Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Foot and Mouth Disease (FMD) Vaccines Sales by Application (2021-2026) & (M Doses) Table 66. Asia-Pacific Foot and Mouth Disease (FMD) Vaccines Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Foot and Mouth Disease (FMD) Vaccines Sales by Application (2021-2026) & (M Doses) Table 68. Latin America Foot and Mouth Disease (FMD) Vaccines Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Sales by Application (2021-2026) & (M Doses) Table 70. Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Sales by Application (2021-2026) & (US$ Million) Table 71. Jinyu Group Company Information Table 72. Jinyu Group Business Overview Table 73. Jinyu Group Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 74. Jinyu Group Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 75. Jinyu Group Recent Development Table 76. Cavet Bio Company Information Table 77. Cavet Bio Business Overview Table 78. Cavet Bio Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 79. Cavet Bio Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 80. Cavet Bio Recent Development Table 81. Indian Immunologicals Company Information Table 82. Indian Immunologicals Business Overview Table 83. Indian Immunologicals Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 84. Indian Immunologicals Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 85. Indian Immunologicals Recent Development Table 86. Tecon Group Company Information Table 87. Tecon Group Business Overview Table 88. Tecon Group Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 89. Tecon Group Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 90. Tecon Group Recent Development Table 91. CAHIC Company Information Table 92. CAHIC Business Overview Table 93. CAHIC Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 94. CAHIC Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 95. CAHIC Recent Development Table 96. Shen Lian Company Information Table 97. Shen Lian Business Overview Table 98. Shen Lian Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 99. Shen Lian Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 100. Shen Lian Recent Development Table 101. Biogenesis Bagó Company Information Table 102. Biogenesis Bagó Business Overview Table 103. Biogenesis Bagó Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 104. Biogenesis Bagó Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 105. Biogenesis Bagó Recent Development Table 106. BIGVET Biotech Company Information Table 107. BIGVET Biotech Business Overview Table 108. BIGVET Biotech Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 109. BIGVET Biotech Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 110. BIGVET Biotech Recent Development Table 111. Boehringer Ingelheim Company Information Table 112. Boehringer Ingelheim Business Overview Table 113. Boehringer Ingelheim Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 114. Boehringer Ingelheim Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 115. Boehringer Ingelheim Recent Development Table 116. MSD Animal Health Company Information Table 117. MSD Animal Health Business Overview Table 118. MSD Animal Health Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 119. MSD Animal Health Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 120. MSD Animal Health Recent Development Table 121. CEVA Company Information Table 122. CEVA Business Overview Table 123. CEVA Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 124. CEVA Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 125. CEVA Recent Development Table 126. FGBI Company Information Table 127. FGBI Business Overview Table 128. FGBI Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 129. FGBI Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 130. FGBI Recent Development Table 131. Bayer HealthCare Company Information Table 132. Bayer HealthCare Business Overview Table 133. Bayer HealthCare Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 134. Bayer HealthCare Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 135. Bayer HealthCare Recent Development Table 136. Brilliant Bio Pharma Company Information Table 137. Brilliant Bio Pharma Business Overview Table 138. Brilliant Bio Pharma Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 139. Brilliant Bio Pharma Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 140. Brilliant Bio Pharma Recent Development Table 141. VECOL Company Information Table 142. VECOL Business Overview Table 143. VECOL Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 144. VECOL Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 145. VECOL Recent Development Table 146. Sanofi (Merial) Company Information Table 147. Sanofi (Merial) Business Overview Table 148. Sanofi (Merial) Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 149. Sanofi (Merial) Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 150. Sanofi (Merial) Recent Development Table 151. VETAL Company Information Table 152. VETAL Business Overview Table 153. VETAL Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 154. VETAL Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 155. VETAL Recent Development Table 156. BVI Company Information Table 157. BVI Business Overview Table 158. BVI Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 159. BVI Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 160. BVI Recent Development Table 161. LIMOR Company Information Table 162. LIMOR Business Overview Table 163. LIMOR Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 164. LIMOR Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 165. LIMOR Recent Development Table 166. ME VAC Company Information Table 167. ME VAC Business Overview Table 168. ME VAC Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 169. ME VAC Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 170. ME VAC Recent Development Table 171. Agrovet Company Information Table 172. Agrovet Business Overview Table 173. Agrovet Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 174. Agrovet Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 175. Agrovet Recent Development Table 176. North America Foot and Mouth Disease (FMD) Vaccines Market Size Growth Rate (CAGR) by Country (M Doses): 2021 VS 2025 VS 2032 Table 177. North America Foot and Mouth Disease (FMD) Vaccines Sales by Country (2021-2026) & (M Doses) Table 178. North America Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Country (2021-2026) Table 179. North America Foot and Mouth Disease (FMD) Vaccines Sales Forecast by Country (2027-2032) & (M Doses) Table 180. North America Foot and Mouth Disease (FMD) Vaccines Sales Market Share Forecast by Country (2027-2032) Table 181. North America Foot and Mouth Disease (FMD) Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 182. North America Foot and Mouth Disease (FMD) Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 183. North America Foot and Mouth Disease (FMD) Vaccines Market Share by Country (2021-2026) Table 184. North America Foot and Mouth Disease (FMD) Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 185. North America Foot and Mouth Disease (FMD) Vaccines Market Share Forecast by Country (2027-2032) Table 186. Europe Foot and Mouth Disease (FMD) Vaccines Market Size Growth Rate (CAGR) by Country (M Doses): 2021 VS 2025 VS 2032 Table 187. Europe Foot and Mouth Disease (FMD) Vaccines Sales by Country (2021-2026) & (M Doses) Table 188. Europe Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Country (2021-2026) Table 189. Europe Foot and Mouth Disease (FMD) Vaccines Sales Forecast by Country (2027-2032) & (M Doses) Table 190. Europe Foot and Mouth Disease (FMD) Vaccines Sales Market Share Forecast by Country (2027-2032) Table 191. Europe Foot and Mouth Disease (FMD) Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 192. Europe Foot and Mouth Disease (FMD) Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 193. Europe Foot and Mouth Disease (FMD) Vaccines Market Share by Country (2021-2026) Table 194. Europe Foot and Mouth Disease (FMD) Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 195. Europe Foot and Mouth Disease (FMD) Vaccines Market Share Forecast by Country (2027-2032) Table 196. Asia-Pacific Foot and Mouth Disease (FMD) Vaccines Market Size Growth Rate (CAGR) by Country (M Doses): 2021 VS 2025 VS 2032 Table 197. Asia-Pacific Foot and Mouth Disease (FMD) Vaccines Sales by Country (2021-2026) & (M Doses) Table 198. Asia-Pacific Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Country (2021-2026) Table 199. Asia-Pacific Foot and Mouth Disease (FMD) Vaccines Sales Forecast by Country (2027-2032) & (M Doses) Table 200. Asia-Pacific Foot and Mouth Disease (FMD) Vaccines Sales Market Share Forecast by Country (2027-2032) Table 201. Asia-Pacific Foot and Mouth Disease (FMD) Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 202. Asia-Pacific Foot and Mouth Disease (FMD) Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 203. Asia-Pacific Foot and Mouth Disease (FMD) Vaccines Market Share by Country (2021-2026) Table 204. Asia-Pacific Foot and Mouth Disease (FMD) Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 205. Asia-Pacific Foot and Mouth Disease (FMD) Vaccines Market Share Forecast by Country (2027-2032) Table 206. Latin America Foot and Mouth Disease (FMD) Vaccines Market Size Growth Rate (CAGR) by Country (M Doses): 2021 VS 2025 VS 2032 Table 207. Latin America Foot and Mouth Disease (FMD) Vaccines Sales by Country (2021-2026) & (M Doses) Table 208. Latin America Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Country (2021-2026) Table 209. Latin America Foot and Mouth Disease (FMD) Vaccines Sales Forecast by Country (2027-2032) & (M Doses) Table 210. Latin America Foot and Mouth Disease (FMD) Vaccines Sales Market Share Forecast by Country (2027-2032) Table 211. Latin America Foot and Mouth Disease (FMD) Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 212. Latin America Foot and Mouth Disease (FMD) Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 213. Latin America Foot and Mouth Disease (FMD) Vaccines Market Share by Country (2021-2026) Table 214. Latin America Foot and Mouth Disease (FMD) Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 215. Latin America Foot and Mouth Disease (FMD) Vaccines Market Share Forecast by Country (2027-2032) Table 216. Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Market Size Growth Rate (CAGR) by Country (M Doses): 2021 VS 2025 VS 2032 Table 217. Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Sales by Country (2021-2026) & (M Doses) Table 218. Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Country (2021-2026) Table 219. Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Sales Forecast by Country (2027-2032) & (M Doses) Table 220. Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Sales Market Share Forecast by Country (2027-2032) Table 221. Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 222. Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 223. Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Market Share by Country (2021-2026) Table 224. Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 225. Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Market Share Forecast by Country (2027-2032) Table 226. Key Raw Materials Table 227. Raw Materials Key Suppliers Table 228. Foot and Mouth Disease (FMD) Vaccines Distributors List Table 229. Foot and Mouth Disease (FMD) Vaccines Customers List Table 230. Research Programs/Design for This Report Table 231. Authors List of This Report Table 232. Secondary Sources Table 233. Primary Sources List of Figures Figure 1. Foot and Mouth Disease (FMD) Vaccines Image Figure 2. Global Foot and Mouth Disease (FMD) Vaccines Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Foot and Mouth Disease (FMD) Vaccines Market Size (2021-2032) & (US$ Million) Figure 4. Global Foot and Mouth Disease (FMD) Vaccines Sales (2021-2032) & (M Doses) Figure 5. Emergency Vaccines Image Figure 6. Global Emergency Vaccines Sales YoY Growth (2021-2032) & (M Doses) Figure 7. Conventional Vaccines Image Figure 8. Global Conventional Vaccines Sales YoY Growth (2021-2032) & (M Doses) Figure 9. Global Foot and Mouth Disease (FMD) Vaccines Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Foot and Mouth Disease (FMD) Vaccines Market Share by Type 2025 VS 2032 Figure 11. North America Foot and Mouth Disease (FMD) Vaccines Sales Market Share in Volume by Type in 2025 Figure 12. North America Foot and Mouth Disease (FMD) Vaccines Sales Market Share in Value by Type in 2025 Figure 13. Europe Foot and Mouth Disease (FMD) Vaccines Sales Market Share in Volume by Type in 2025 Figure 14. Europe Foot and Mouth Disease (FMD) Vaccines Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Foot and Mouth Disease (FMD) Vaccines Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Foot and Mouth Disease (FMD) Vaccines Sales Market Share in Value by Type in 2025 Figure 17. Latin America Foot and Mouth Disease (FMD) Vaccines Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Foot and Mouth Disease (FMD) Vaccines Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Foot and Mouth Disease (FMD) Vaccines Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Cattle Image Figure 24. Global Cattle Sales YoY Growth (2021-2032) & (M Doses) Figure 25. Pig Image Figure 26. Global Pig Sales YoY Growth (2021-2032) & (M Doses) Figure 27. Sheep and Goat Image Figure 28. Global Sheep and Goat Sales YoY Growth (2021-2032) & (M Doses) Figure 29. Others Image Figure 30. Global Others Sales YoY Growth (2021-2032) & (M Doses) Figure 31. Global Foot and Mouth Disease (FMD) Vaccines Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Foot and Mouth Disease (FMD) Vaccines Market Share by Application 2025 VS 2032 Figure 33. North America Foot and Mouth Disease (FMD) Vaccines Sales Market Share in Volume by Application in 2025 Figure 34. North America Foot and Mouth Disease (FMD) Vaccines Sales Market Share in Value by Application in 2025 Figure 35. Europe Foot and Mouth Disease (FMD) Vaccines Sales Market Share in Volume by Application in 2025 Figure 36. Europe Foot and Mouth Disease (FMD) Vaccines Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Foot and Mouth Disease (FMD) Vaccines Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Foot and Mouth Disease (FMD) Vaccines Sales Market Share in Value by Application in 2025 Figure 39. Latin America Foot and Mouth Disease (FMD) Vaccines Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Foot and Mouth Disease (FMD) Vaccines Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Sales Market Share in Value by Application in 2025 Figure 43. North America Foot and Mouth Disease (FMD) Vaccines Sales by Country: 2021 VS 2025 VS 2032 (M Doses) Figure 44. North America Foot and Mouth Disease (FMD) Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Foot and Mouth Disease (FMD) Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Foot and Mouth Disease (FMD) Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Foot and Mouth Disease (FMD) Vaccines Sales by Country: 2021 VS 2025 VS 2032 (M Doses) Figure 48. Europe Foot and Mouth Disease (FMD) Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Foot and Mouth Disease (FMD) Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Foot and Mouth Disease (FMD) Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Foot and Mouth Disease (FMD) Vaccines Sales by Country: 2021 VS 2025 VS 2032 (M Doses) Figure 52. Asia-Pacific Foot and Mouth Disease (FMD) Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Foot and Mouth Disease (FMD) Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Foot and Mouth Disease (FMD) Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Foot and Mouth Disease (FMD) Vaccines Sales by Country: 2021 VS 2025 VS 2032 (M Doses) Figure 56. Latin America Foot and Mouth Disease (FMD) Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Foot and Mouth Disease (FMD) Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Foot and Mouth Disease (FMD) Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Sales by Country: 2021 VS 2025 VS 2032 (M Doses) Figure 60. Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Foot and Mouth Disease (FMD) Vaccines Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Foot and Mouth Disease (FMD) Vaccines Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Emergency Vaccines
  • Conventional Vaccines
Applications
  • Cattle
  • Pig
  • Sheep and Goat
  • Others
Companies covered
  • Jinyu Group
  • Cavet Bio
  • Indian Immunologicals
  • Tecon Group
  • CAHIC
  • Shen Lian
  • Biogenesis Bagó
  • BIGVET Biotech
  • Boehringer Ingelheim
  • MSD Animal Health
  • CEVA
  • FGBI
  • Bayer HealthCare
  • Brilliant Bio Pharma
  • VECOL
  • Sanofi (Merial)
  • VETAL
  • BVI
  • LIMOR
  • ME VAC
  • Agrovet

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Foot and Mouth Disease (FMD) Vaccines Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Foot and Mouth Disease (FMD) Vaccines Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Foot and Mouth Disease (FMD) Vaccines Market by Type
  6. 1.3.1 Emergency Vaccines
  7. 1.3.2 Conventional Vaccines
  8. 1.4 Global Foot and Mouth Disease (FMD) Vaccines Market Size by Type
  9. 1.4.1 Global Foot and Mouth Disease (FMD) Vaccines Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Foot and Mouth Disease (FMD) Vaccines Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Foot and Mouth Disease (FMD) Vaccines Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Foot and Mouth Disease (FMD) Vaccines Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Foot and Mouth Disease (FMD) Vaccines Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Foot and Mouth Disease (FMD) Vaccines Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Foot and Mouth Disease (FMD) Vaccines Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Foot and Mouth Disease (FMD) Vaccines Industry Trends
  2. 2.2 Foot and Mouth Disease (FMD) Vaccines Industry Drivers
  3. 2.3 Foot and Mouth Disease (FMD) Vaccines Industry Opportunities and Challenges
  4. 2.4 Foot and Mouth Disease (FMD) Vaccines Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Foot and Mouth Disease (FMD) Vaccines Revenue (2021-2026)
  2. 3.2 Global Top Players by Foot and Mouth Disease (FMD) Vaccines Sales (2021-2026)
  3. 3.3 Global Top Players by Foot and Mouth Disease (FMD) Vaccines Price (2021-2026)
  4. 3.4 Global Foot and Mouth Disease (FMD) Vaccines Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Foot and Mouth Disease (FMD) Vaccines Major Company Production Sites & Headquarters
  6. 3.6 Global Foot and Mouth Disease (FMD) Vaccines Company, Product Type & Application
  7. 3.7 Global Foot and Mouth Disease (FMD) Vaccines Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Foot and Mouth Disease (FMD) Vaccines Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Foot and Mouth Disease (FMD) Vaccines Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Foot and Mouth Disease (FMD) Vaccines Tier 1, Tier 2, and Tier 3
4 Foot and Mouth Disease (FMD) Vaccines Regional Status and Outlook
  1. 4.1 Global Foot and Mouth Disease (FMD) Vaccines Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Foot and Mouth Disease (FMD) Vaccines Historic Market Size by Region
  3. 4.2.1 Global Foot and Mouth Disease (FMD) Vaccines Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Foot and Mouth Disease (FMD) Vaccines Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Foot and Mouth Disease (FMD) Vaccines Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Foot and Mouth Disease (FMD) Vaccines Forecasted Market Size by Region
  7. 4.3.1 Global Foot and Mouth Disease (FMD) Vaccines Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Foot and Mouth Disease (FMD) Vaccines Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Foot and Mouth Disease (FMD) Vaccines Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Foot and Mouth Disease (FMD) Vaccines by Application
  1. 5.1 Foot and Mouth Disease (FMD) Vaccines Market by Application
  2. 5.1.1 Cattle
  3. 5.1.2 Pig
  4. 5.1.3 Sheep and Goat
  5. 5.1.4 Others
  6. 5.2 Global Foot and Mouth Disease (FMD) Vaccines Market Size by Application
  7. 5.2.1 Global Foot and Mouth Disease (FMD) Vaccines Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Foot and Mouth Disease (FMD) Vaccines Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Foot and Mouth Disease (FMD) Vaccines Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Foot and Mouth Disease (FMD) Vaccines Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Foot and Mouth Disease (FMD) Vaccines Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Foot and Mouth Disease (FMD) Vaccines Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Foot and Mouth Disease (FMD) Vaccines Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Jinyu Group
  2. 6.1.1 Jinyu Group Company Information
  3. 6.1.2 Jinyu Group Business Overview
  4. 6.1.3 Jinyu Group Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Jinyu Group Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  6. 6.1.5 Jinyu Group Recent Developments
  7. 6.2 Cavet Bio
  8. 6.2.1 Cavet Bio Company Information
  9. 6.2.2 Cavet Bio Business Overview
  10. 6.2.3 Cavet Bio Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Cavet Bio Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  12. 6.2.5 Cavet Bio Recent Developments
  13. 6.3 Indian Immunologicals
  14. 6.3.1 Indian Immunologicals Company Information
  15. 6.3.2 Indian Immunologicals Business Overview
  16. 6.3.3 Indian Immunologicals Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Indian Immunologicals Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  18. 6.3.5 Indian Immunologicals Recent Developments
  19. 6.4 Tecon Group
  20. 6.4.1 Tecon Group Company Information
  21. 6.4.2 Tecon Group Business Overview
  22. 6.4.3 Tecon Group Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Tecon Group Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  24. 6.4.5 Tecon Group Recent Developments
  25. 6.5 CAHIC
  26. 6.5.1 CAHIC Company Information
  27. 6.5.2 CAHIC Business Overview
  28. 6.5.3 CAHIC Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 CAHIC Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  30. 6.5.5 CAHIC Recent Developments
  31. 6.6 Shen Lian
  32. 6.6.1 Shen Lian Company Information
  33. 6.6.2 Shen Lian Business Overview
  34. 6.6.3 Shen Lian Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Shen Lian Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  36. 6.6.5 Shen Lian Recent Developments
  37. 6.7 Biogenesis Bagó
  38. 6.7.1 Biogenesis Bagó Company Information
  39. 6.7.2 Biogenesis Bagó Business Overview
  40. 6.7.3 Biogenesis Bagó Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Biogenesis Bagó Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  42. 6.7.5 Biogenesis Bagó Recent Developments
  43. 6.8 BIGVET Biotech
  44. 6.8.1 BIGVET Biotech Company Information
  45. 6.8.2 BIGVET Biotech Business Overview
  46. 6.8.3 BIGVET Biotech Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 BIGVET Biotech Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  48. 6.8.5 BIGVET Biotech Recent Developments
  49. 6.9 Boehringer Ingelheim
  50. 6.9.1 Boehringer Ingelheim Company Information
  51. 6.9.2 Boehringer Ingelheim Business Overview
  52. 6.9.3 Boehringer Ingelheim Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Boehringer Ingelheim Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  54. 6.9.5 Boehringer Ingelheim Recent Developments
  55. 6.10 MSD Animal Health
  56. 6.10.1 MSD Animal Health Company Information
  57. 6.10.2 MSD Animal Health Business Overview
  58. 6.10.3 MSD Animal Health Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 MSD Animal Health Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  60. 6.10.5 MSD Animal Health Recent Developments
  61. 6.11 CEVA
  62. 6.11.1 CEVA Company Information
  63. 6.11.2 CEVA Business Overview
  64. 6.11.3 CEVA Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 CEVA Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  66. 6.11.5 CEVA Recent Developments
  67. 6.12 FGBI
  68. 6.12.1 FGBI Company Information
  69. 6.12.2 FGBI Business Overview
  70. 6.12.3 FGBI Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 FGBI Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  72. 6.12.5 FGBI Recent Developments
  73. 6.13 Bayer HealthCare
  74. 6.13.1 Bayer HealthCare Company Information
  75. 6.13.2 Bayer HealthCare Business Overview
  76. 6.13.3 Bayer HealthCare Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Bayer HealthCare Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  78. 6.13.5 Bayer HealthCare Recent Developments
  79. 6.14 Brilliant Bio Pharma
  80. 6.14.1 Brilliant Bio Pharma Company Information
  81. 6.14.2 Brilliant Bio Pharma Business Overview
  82. 6.14.3 Brilliant Bio Pharma Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Brilliant Bio Pharma Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  84. 6.14.5 Brilliant Bio Pharma Recent Developments
  85. 6.15 VECOL
  86. 6.15.1 VECOL Company Information
  87. 6.15.2 VECOL Business Overview
  88. 6.15.3 VECOL Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 VECOL Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  90. 6.15.5 VECOL Recent Developments
  91. 6.16 Sanofi (Merial)
  92. 6.16.1 Sanofi (Merial) Company Information
  93. 6.16.2 Sanofi (Merial) Business Overview
  94. 6.16.3 Sanofi (Merial) Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Sanofi (Merial) Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  96. 6.16.5 Sanofi (Merial) Recent Developments
  97. 6.17 VETAL
  98. 6.17.1 VETAL Company Information
  99. 6.17.2 VETAL Business Overview
  100. 6.17.3 VETAL Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 VETAL Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  102. 6.17.5 VETAL Recent Developments
  103. 6.18 BVI
  104. 6.18.1 BVI Company Information
  105. 6.18.2 BVI Business Overview
  106. 6.18.3 BVI Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 BVI Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  108. 6.18.5 BVI Recent Developments
  109. 6.19 LIMOR
  110. 6.19.1 LIMOR Company Information
  111. 6.19.2 LIMOR Business Overview
  112. 6.19.3 LIMOR Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2021-2026)
  113. 6.19.4 LIMOR Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  114. 6.19.5 LIMOR Recent Developments
  115. 6.20 ME VAC
  116. 6.20.1 ME VAC Company Information
  117. 6.20.2 ME VAC Business Overview
  118. 6.20.3 ME VAC Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2021-2026)
  119. 6.20.4 ME VAC Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  120. 6.20.5 ME VAC Recent Developments
  121. 6.21 Agrovet
  122. 6.21.1 Agrovet Company Information
  123. 6.21.2 Agrovet Business Overview
  124. 6.21.3 Agrovet Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2021-2026)
  125. 6.21.4 Agrovet Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  126. 6.21.5 Agrovet Recent Developments
7 North America by Country
  1. 7.1 North America Foot and Mouth Disease (FMD) Vaccines Sales by Country
  2. 7.1.1 North America Foot and Mouth Disease (FMD) Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Foot and Mouth Disease (FMD) Vaccines Sales by Country (2021-2026)
  4. 7.1.3 North America Foot and Mouth Disease (FMD) Vaccines Sales Forecast by Country (2027-2032)
  5. 7.2 North America Foot and Mouth Disease (FMD) Vaccines Market Size by Country
  6. 7.2.1 North America Foot and Mouth Disease (FMD) Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Foot and Mouth Disease (FMD) Vaccines Market Size by Country (2021-2026)
  8. 7.2.3 North America Foot and Mouth Disease (FMD) Vaccines Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Foot and Mouth Disease (FMD) Vaccines Sales by Country
  2. 8.1.1 Europe Foot and Mouth Disease (FMD) Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Foot and Mouth Disease (FMD) Vaccines Sales by Country (2021-2026)
  4. 8.1.3 Europe Foot and Mouth Disease (FMD) Vaccines Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Foot and Mouth Disease (FMD) Vaccines Market Size by Country
  6. 8.2.1 Europe Foot and Mouth Disease (FMD) Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Foot and Mouth Disease (FMD) Vaccines Market Size by Country (2021-2026)
  8. 8.2.3 Europe Foot and Mouth Disease (FMD) Vaccines Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Foot and Mouth Disease (FMD) Vaccines Sales by Country
  2. 9.1.1 Asia-Pacific Foot and Mouth Disease (FMD) Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Foot and Mouth Disease (FMD) Vaccines Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Foot and Mouth Disease (FMD) Vaccines Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Foot and Mouth Disease (FMD) Vaccines Market Size by Country
  6. 9.2.1 Asia-Pacific Foot and Mouth Disease (FMD) Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Foot and Mouth Disease (FMD) Vaccines Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Foot and Mouth Disease (FMD) Vaccines Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Foot and Mouth Disease (FMD) Vaccines Sales by Country
  2. 10.1.1 South America Foot and Mouth Disease (FMD) Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Foot and Mouth Disease (FMD) Vaccines Sales by Country (2021-2026)
  4. 10.1.3 South America Foot and Mouth Disease (FMD) Vaccines Sales Forecast by Country (2027-2032)
  5. 10.2 South America Foot and Mouth Disease (FMD) Vaccines Market Size by Country
  6. 10.2.1 South America Foot and Mouth Disease (FMD) Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Foot and Mouth Disease (FMD) Vaccines Market Size by Country (2021-2026)
  8. 10.2.3 South America Foot and Mouth Disease (FMD) Vaccines Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Sales by Country
  2. 11.1.1 Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Market Size by Country
  6. 11.2.1 Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Foot and Mouth Disease (FMD) Vaccines Value Chain Analysis
  2. 12.1.1 Foot and Mouth Disease (FMD) Vaccines Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Foot and Mouth Disease (FMD) Vaccines Production Mode & Process
  7. 12.2 Foot and Mouth Disease (FMD) Vaccines Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Foot and Mouth Disease (FMD) Vaccines Distributors
  10. 12.2.3 Foot and Mouth Disease (FMD) Vaccines Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst